Guardian Pharmacy Services, Inc.
GRDN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $377 | $344 | $329 | $339 |
| % Growth | 9.6% | 4.6% | -2.7% | – |
| Cost of Goods Sold | $303 | $276 | $265 | $271 |
| Gross Profit | $75 | $68 | $64 | $67 |
| % Margin | 19.8% | 19.8% | 19.5% | 19.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $58 | $56 | $51 | $50 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $58 | $56 | $51 | $50 |
| Operating Income | $16 | $13 | $13 | $17 |
| % Margin | 4.3% | 3.7% | 3.9% | 4.9% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$1 |
| Pre-Tax Income | $17 | $13 | $13 | $16 |
| Tax Expense | $7 | $4 | $4 | $4 |
| Net Income | $10 | $9 | $9 | $12 |
| % Margin | 2.6% | 2.6% | 2.9% | 3.5% |
| EPS | 0.16 | 0.15 | 0.15 | 0.2 |
| % Growth | 6.7% | 0% | -25% | – |
| EPS Diluted | 0.15 | 0.14 | 0.15 | 0.2 |
| Weighted Avg Shares Out | 62 | 62 | 62 | 61 |
| Weighted Avg Shares Out Dil | 63 | 63 | 63 | 61 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7 | $5 | $5 | $5 |
| EBITDA | $24 | $18 | $19 | $22 |
| % Margin | 6.3% | 5.3% | 5.6% | 6.4% |